Latest update on Euroneut41 Project- HIV Vaccine

Vicky Betts's picture
Vicky Betts
16 December 2013

The Surrey Clinical Research Centre was recently at the centre of an international effort with European Commission funding to design and test a vaccine to prevent HIV/AIDS. The vaccine employed several highly innovative concepts including nasal delivery to produce strong genital tract immunity, liposomal formulation, and an uniquely designed active component to make virus-blocking antibodies. The SCRC conducted the first in human clinical trial of this product, drawing on its extensive expertise in translational medicine, mucosal immunology, and Phase 1 trial accreditation. A short video was made about the EURONEUT41 project by the European Commission as part of its initiative to enhance awareness of cutting-edge EU sponsored research in high priority areas of medical need.